Published in Am J Trop Med Hyg on November 01, 2004
The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet (2011) 5.42
Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malar J (2008) 3.73
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ (2009) 2.84
Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Malar J (2007) 2.33
The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial. PLoS Med (2011) 1.99
Mobile phone text messaging: tool for malaria control in Africa. PLoS Med (2012) 1.88
Health worker performance in the management of paediatric fevers following in-service training and exposure to job aids in Kenya. Malar J (2010) 1.58
Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya. East Afr Med J (2008) 1.43
Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malar J (2010) 1.43
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya. Malar J (2011) 1.42
Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia. Malar J (2011) 1.41
The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya. Malar J (2012) 1.39
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. Malar J (2006) 1.37
Therapeutic efficacy of Artemether/Lumefantrine (Coartem(R)) against Plasmodium falciparum in Kersa, South West Ethiopia. Parasit Vectors (2010) 1.35
Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda. Malar J (2012) 1.28
Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence. Malar J (2014) 1.26
Malaria treatment policy change and implementation: the case of Uganda. Malar Res Treat (2011) 1.25
Progress towards implementation of ACT malaria case-management in public health facilities in the Republic of Sudan: a cluster-sample survey. BMC Public Health (2012) 1.23
Effective coverage and systems effectiveness for malaria case management in sub-Saharan African countries. PLoS One (2015) 1.16
How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs. PLoS One (2014) 1.15
High adherence to antimalarials and antibiotics under integrated community case management of illness in children less than five years in eastern Uganda. PLoS One (2013) 1.13
The reality of using primaquine. Malar J (2010) 1.12
Community response to artemisinin-based combination therapy for childhood malaria: a case study from Dar es Salaam, Tanzania. Malar J (2010) 1.06
Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden. Malar J (2013) 1.05
Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal. Malar J (2009) 1.04
Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda. Malar J (2013) 1.02
Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother (2005) 0.99
Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya. PLoS One (2013) 0.95
Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment. Parasitology (2014) 0.93
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling. Malar J (2014) 0.92
The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana. Malar J (2014) 0.92
Adherence to artemether-lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania. Malar J (2014) 0.91
Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya. Malar J (2014) 0.89
Intervention to promote patients' adherence to antimalarial medication: a systematic review. Am J Trop Med Hyg (2013) 0.88
Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants. Malar J (2010) 0.87
Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal. Malar J (2009) 0.87
Challenges Associated with Scaling up Artemisinin Combination Therapy in Sub-Saharan Africa A Review Article. Libyan J Med (2008) 0.87
Levels of adherence to coartem© in the routine treatment of uncomplicated malaria in children aged below five years, in kenya. Iran J Public Health (2013) 0.86
Patient related factors affecting adherence to antimalarial medication in an urban estate in ghana. Malar Res Treat (2015) 0.86
Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting. Malar J (2015) 0.81
Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study. PLoS One (2016) 0.81
Measuring Patient Adherence to Malaria Treatment: A Comparison of Results from Self-Report and a Customised Electronic Monitoring Device. PLoS One (2015) 0.80
What influences availability of medicines for the community management of childhood illnesses in central Uganda? Implications for scaling up the integrated community case management programme. BMC Public Health (2015) 0.79
Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study. Malar J (2016) 0.79
Adherence to Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria: A Systematic Review and Meta-Analysis. J Trop Med (2015) 0.79
The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya. PLoS One (2015) 0.78
Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia. Ther Clin Risk Manag (2016) 0.78
Prolonged elevation of viral loads in HIV-1-infected children in a region of intense malaria transmission in Northern Uganda: a prospective cohort study. Pan Afr Med J (2010) 0.76
Efficacy of text-message reminders on paediatric malaria treatment adherence and their post-treatment return to health facilities in Kenya: a randomized controlled trial. Malar J (2017) 0.76
Adherence to Artemisinin Combination Therapy for the treatment of uncomplicated malaria in the Democratic Republic of the Congo. F1000Res (2015) 0.76
High adherence to malaria treatment: promising results of an adherence study in South Kivu, Democratic Republic of the Congo. Malar J (2015) 0.75
Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance. BMC Pharmacol Toxicol (2015) 0.75
Rational use of antibiotics by community health workers and caregivers for children with suspected pneumonia in Zambia: a cross-sectional mixed methods study. BMC Public Health (2016) 0.75
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis (2007) 4.35
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
Health-care needs of people affected by conflict: future trends and changing frameworks. Lancet (2010) 3.82
A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. Mol Biol Evol (2003) 3.67
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Violence and mortality in West Darfur, Sudan (2003-04): epidemiological evidence from four surveys. Lancet (2004) 3.14
HIV prevalence and incidence are no longer falling in southwest Uganda: evidence from a rural population cohort 1989-2005. AIDS (2008) 3.01
Psychological distress among AIDS orphans in rural Uganda. Soc Sci Med (2005) 2.88
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother (2004) 2.77
Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda. Trans R Soc Trop Med Hyg (2002) 2.66
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One (2009) 2.43
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health (2006) 2.39
Selection strength and hitchhiking around two anti-malarial resistance genes. Proc Biol Sci (2005) 2.04
Herpes simplex virus type 2: a key role in HIV incidence. AIDS (2009) 2.03
Malaria epidemics and interventions, Kenya, Burundi, southern Sudan, and Ethiopia, 1999-2004. Emerg Infect Dis (2006) 2.01
Assessment of three new parasite lactate dehydrogenase (pan-pLDH) tests for diagnosis of uncomplicated malaria. Trans R Soc Trop Med Hyg (2007) 2.00
High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. Am J Trop Med Hyg (2006) 1.92
Brain drain in sub-Saharan Africa: contributing factors, potential remedies and the role of academic medical centres. Arch Dis Child (2012) 1.86
Pre-emptive war epidemiology: lessons from the Democratic Republic of Congo. Lancet (2006) 1.83
Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage. J Clin Microbiol (2005) 1.82
Community acceptability of use of rapid diagnostic tests for malaria by community health workers in Uganda. Malar J (2010) 1.81
Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. Malar J (2006) 1.80
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J (2009) 1.80
High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis (2006) 1.77
Peer-group support intervention improves the psychosocial well-being of AIDS orphans: cluster randomized trial. Soc Sci Med (2009) 1.73
The burden of acute respiratory infections in crisis-affected populations: a systematic review. Confl Health (2010) 1.72
Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series. PLoS Negl Trop Dis (2007) 1.72
Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda. PLoS Clin Trials (2006) 1.72
Don't spin the pen: two alternative methods for second-stage sampling in urban cluster surveys. Emerg Themes Epidemiol (2007) 1.71
Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda. J Clin Microbiol (2005) 1.67
Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health (2004) 1.61
Evaluation of three rapid tests for diagnosis of P. falciparum and P. vivax malaria in Colombia. Am J Trop Med Hyg (2006) 1.60
Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites. Mol Biol Evol (2005) 1.56
Evaluation of the benefits and risks of introducing Ebola community care centers, Sierra Leone. Emerg Infect Dis (2015) 1.56
Death rates from malaria epidemics, Burundi and Ethiopia. Emerg Infect Dis (2007) 1.51
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg (2014) 1.51
HIV incidence and recent injections among adults in rural southwestern Uganda. AIDS (2007) 1.48
Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health (2011) 1.43
Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Bull World Health Organ (2006) 1.43
Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe. Tuberculosis (Edinb) (2009) 1.43
Malaria in camps for internally-displaced persons in Uganda: evaluation of an insecticide-treated bednet distribution programme. Trans R Soc Trop Med Hyg (2004) 1.40
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. Malar J (2006) 1.37
Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine (2010) 1.37
Mortality among displaced former UNITA members and their families in Angola: a retrospective cluster survey. BMJ (2003) 1.36
Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. Antimicrob Agents Chemother (2006) 1.36
The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria. Malar J (2008) 1.29
Users' guides to the medical literature: how to use an article about mortality in a humanitarian emergency. Confl Health (2008) 1.28
Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment. Malar J (2013) 1.26
Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Bull World Health Organ (2006) 1.25
Lay workers in directly observed treatment (DOT) programmes for tuberculosis in high burden settings: Should they be paid? A review of behavioural perspectives. Afr Health Sci (2002) 1.25
The uncertain burden of Plasmodium falciparum epidemics in Africa. Trends Parasitol (2007) 1.22
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations. Trans R Soc Trop Med Hyg (2005) 1.22
Public health surveillance after the 2010 haiti earthquake: the experience of médecins sans frontières. PLoS Curr (2013) 1.21
Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda. J Acquir Immune Defic Syndr (2003) 1.19
Identifying transmission cycles at the human-animal interface: the role of animal reservoirs in maintaining gambiense human african trypanosomiasis. PLoS Comput Biol (2013) 1.19
Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment. Trop Med Int Health (2008) 1.18
Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone. Trop Med Int Health (2006) 1.18
A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda. AIDS Res Hum Retroviruses (2008) 1.16
Lost opportunities to reduce periconception HIV transmission: safer conception counseling by South African providers addresses perinatal but not sexual HIV transmission. J Acquir Immune Defic Syndr (2014) 1.15
Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia. Trop Med Int Health (2005) 1.14
Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan. Malar J (2005) 1.10
Nutritional status of children living in a community with high HIV prevalence in rural Uganda: a cross-sectional population-based survey. Trop Med Int Health (2010) 1.10
Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans R Soc Trop Med Hyg (2008) 1.09
Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies. J Clin Microbiol (2007) 1.08
Sentinel site community surveillance of mortality and nutritional status in southwestern Central African Republic, 2010. Popul Health Metr (2012) 1.08
Performance of a histidine-rich protein 2 rapid diagnostic test, Paracheck Pf®, for detection of malaria infections in Ugandan pregnant women. Am J Trop Med Hyg (2012) 1.03
Using in-depth qualitative data to enhance our understanding of quantitative results regarding the impact of HIV and AIDS on households in rural Uganda. Soc Sci Med (2008) 1.03
Use of postpartum health services in rural Uganda: knowledge, attitudes, and barriers. J Community Health (2006) 1.02
Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial. Trans R Soc Trop Med Hyg (2004) 1.02
Community coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introduction. Malar J (2007) 1.01
Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali. Trans R Soc Trop Med Hyg (2006) 1.01
A new method to estimate mortality in crisis-affected and resource-poor settings: validation study. Int J Epidemiol (2010) 1.01
The burden of tuberculosis in crisis-affected populations: a systematic review. Lancet Infect Dis (2012) 1.00
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda. Malar J (2012) 1.00
Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda. Trop Med Int Health (2004) 1.00
Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection. PLoS One (2011) 0.99
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med (2015) 0.99